Mycobacterium chimaera as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards
ANNA T. ZABOST
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Profil OrcidWyszukaj tego autora
, , SYLWIA A. BRZEZIŃSKA
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Profil OrcidWyszukaj tego autora
, MAGDALENA D. KLATT
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Profil OrcidWyszukaj tego autora
oraz EWA M. AUGUSTYNOWICZ-KOPEĆ
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Profil OrcidWyszukaj tego autora
17 wrz 2021
O artykule
Kategoria artykułu: original-paper
Data publikacji: 17 wrz 2021
Zakres stron: 315 - 320
Otrzymano: 31 mar 2021
Przyjęty: 08 lip 2021
DOI: https://doi.org/10.33073/pjm-2021-028
Słowa kluczowe
© 2021 Anna T. Zabost et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Fig. 1.
Pathogenicity of isolated M_ chimaera strains depending on sex, age, and concomitant pulmonary disease_
| NTMLD | Colonization | Total | ||
|---|---|---|---|---|
| Sex | ||||
| Men | 8 (50) | 8 (50) | 16(100) | |
| Women | 8 (57) | 6(43) | 14(100) | 0,86 |
| Age | ||||
| Years (mean+/-SD) | 58,3 (16,77) | 62,1 (12,86) | 60,1 (15,19) | 0,72 |
| Diagnosis | ||||
| Previous tuberculosis | 5 (83) | 1 (17) | 6 (100) | |
| COPD | 3 (38) | 5 (62) | 8 (100) | |
| Cystic fibrosis | 2(100) | 0 | 2 (100) | |
| Interstitial lung diseases | 2 (40) | 3 (60) | 5 (100) | |
| Post-inflammatory lung fibrosis | 0 | 3 (100) | 3 (100) | |
| Bronchiectasis | 4(100) | 0 | 4(100) | |
| Neoplastic diseases | 1 (50) | 1 (50) | 2 (100) | |
| Diabetes mellitus | 1 (50) | 1 (50) | 2 (100) | |
| Others | 0 | 4 (100) | 4 (100) | |
| No concomitant disease | 2(100) | 0 | 2 (100) | |
Clinical characteristics of patients with positive M_ chimaera isolates_
| Concomitant diseases | Number (%) of patients with a given diagnosis | ||
|---|---|---|---|
| Men | Women | Total | |
| COPD | 7 (44) | 1 (7) | 8 (27) |
| Previous tuberculosis | 5 (31) | 1 (7) | 6 (20) |
| Interstitial lung disease | 5 (31) | 0 | 5 (17) |
| Cystic fibrosis | 0 | 2 (14) | 2 (7) |
| Post-inflammatory lung fibrosis | 1 (6) | 2 (14) | 3 (10) |
| Bronchiectasis | 1 (6) | 3 (21) | 4 (13) |
| Neoplastic disease | 2 (13) | 0 | 2 (7) |
| Diabetes mellitus | 1 (6) | 1 (7) | 2 (7) |
| Others | 0 | 4 (21) | 4 (13) |
| At least 2 diagnoses | 5 (31) | 2 (14) | 7 (23) |
| No concomitant disease | 1 (6) | 1 (7) | 2 (7) |